îæ€çŽ¢
îæ€çŽ¢
î
Lipocine Inc
LPCNîãŠã©ãããªã¹ãã«è¿œå
2.390USD
-0.070-2.85%
çµå€Â 07/02, 13:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
14.72Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-07-02Lipocine Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯7.00ã§ããã€ãªãã¯ãããžãŒ & å»çç 究æ¥çã§ã¯387瀟äž314äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯6.88ã§ãæé«ã¯7.00ãæäœã¯6.75ã§ãã
ã¢ããªã¹ãè©äŸ¡
2
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
6.000
ç®æšæ ªäŸ¡
+143.90%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
562
åèš
5
äžå€®å€
6
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Lipocine Inc
LPCN
2
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
Lipocine Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îLipocine Inc ã®äºæ³åç㯠156.50K ã§ãã
Lipocine Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãLipocine Inc ã®ç®æšæ ªäŸ¡ã USD 6.88 ãšäºæ³ããæé«äºæ³ã¯ USD 7.00ãæäœäºæ³ã¯ USD 6.75 ãšäºæ³ããŠããŸãã
Lipocine IncLPCN ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.54 ã§ããããLipocine IncLPCN ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.42 ã§ããã次ã®ååæã® EPS 㯠USD -0.43 ãšäºæ³ãããŸãã
Lipocine Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î2 ã¢ããªã¹ãã«ãã Lipocine Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Lipocine Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã